OKYO Pharma Ltd ADR Cash Flow-to-Debt Ratio
OKYO Pharma Ltd ADR cash flow-to-debt ratio. OKYO Pharma Ltd ADR (OKYO) has a Cash Flow-to-Debt Ratio of -0.51x as of June 2026, meaning its operating cash flow of $-4.41 Million could theoretically repay -1% of its total liabilities ($8.64 Million) in one year. Check OKYO cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of OKYO Pharma Ltd ADR (2008–2026)
Cash flow-to-debt ratio of OKYO Pharma Ltd ADR from 2008 to 2026. Historical debt coverage capacity for OKYO Pharma Ltd ADR across 19 annual periods. Also explore net asset momentum of OKYO Pharma Ltd ADR to track the company's year-over-year net asset growth rate.
OKYO Pharma Ltd ADR Cash Flow-to-Debt Ratio by Year (2008–2026)
OKYO Pharma Ltd ADR cash flow-to-debt ratio by year from 2008 to 2026. Year-by-year debt coverage analysis for OKYO Pharma Ltd ADR. For the full cash flow conversion analysis, see OKYO Pharma Ltd ADR (OKYO) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -0.69x | $-5.94 Million | $8.64 Million | ▼ -250.0% |
| 2025 | -0.20x | $-1.81 Million | $9.23 Million | ▲ +84.7% |
| 2024 | -1.28x | $-9.49 Million | $7.42 Million | ▼ -20.6% |
| 2023 | -1.06x | $-7.70 Million | $7.26 Million | ▲ +73.8% |
| 2022 | -4.04x | $-5.47 Million | $1.35 Million | ▼ -347.4% |
| 2021 | -0.90x | $-1.60 Million | $1.77 Million | ▲ +44.6% |
| 2020 | -1.63x | $-1.20 Million | $737.20K | ▲ +65.0% |
| 2019 | -4.66x | $-1.99 Million | $426.72K | ▲ +73.4% |
| 2018 | -17.51x | $-1.59 Million | $91.06K | ▼ -595.9% |
| 2017 | -2.52x | $-651.27K | $258.76K | ▲ +29.9% |
| 2016 | -3.59x | $-650.88K | $181.34K | ▲ +61.7% |
| 2015 | -9.38x | $-1.42 Million | $151.07K | ▲ +32.6% |
| 2014 | -13.93x | $-3.45 Million | $247.95K | ▲ +33.2% |
| 2013 | -20.85x | $-3.82 Million | $183.32K | ▼ -271.7% |
| 2012 | -5.61x | $-4.67 Million | $832.89K | ▲ +66.3% |
| 2011 | -16.63x | $-1.31 Million | $78.74K | ▼ -51.2% |
| 2010 | -11.00x | $-878.61K | $79.87K | ▼ -317.7% |
| 2009 | -2.63x | $-226.35K | $85.96K | ▲ +25.8% |
| 2008 | -3.55x | $-513.95K | $144.86K | — |